Decidual T cells exhibit a highly differentiated phenotype and demonstrate potential fetal specificity and a strong transcriptional response to IFN

Journal of Immunology

Volumn 199, Issue 10, 2017, Pages 3406-3417

  Powell, Richard M ^a   Lissauer, David ^a   Tamblyn, Jennifer ^a   Beggs, Andrew ^a   Cox, Philip ^a   Moss, Paul ^a   Kilby, Mark D ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; HEPATITIS A VIRUS CELLULAR RECEPTOR 2; INTERFERON; INTERLEUKIN 4; LYMPHOCYTE ACTIVATION GENE 3; PROGRAMMED DEATH 1 LIGAND 1; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG; TRANSCRIPTOME;

ALLOREACTIVE T CELL; ANTIGEN SPECIFICITY; ARTICLE; BLOOD; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DECIDUA; EFFECTOR CELL; FEMALE; FETUS; FETUS TISSUE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MALE; MEMORY T LYMPHOCYTE; PHENOTYPIC VARIATION; PREGNANCY; PREGNANCY DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REPRODUCTION; SIGNAL TRANSDUCTION; T CELL DEPLETION; T LYMPHOCYTE; THIRD TRIMESTER PREGNANCY; TRANSCRIPTION REGULATION; CELL CULTURE; DNA RESPONSIVE ELEMENT; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; DECIDUA; FEMALE; FETUS; HUMANS; IMMUNE TOLERANCE; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; INTERFERON-GAMMA; INTERLEUKIN-4; PREGNANCY; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TRANSCRIPTOME;

EID: 85033408729     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1700114     Document Type: Article

References (76)

1. Medawar, P. 1953. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp. Soc. Exp. Biol. 7: 320-338.
2. Ashkar, A. A., J. P. Di Santo, and B. A. Croy. 2000. Interferon g contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J. Exp. Med. 192: 259-270.
3. Lash, G. E., B. Schiessl, M. Kirkley, B. A. Innes, A. Cooper, R. F. Searle, S. C. Robson, and J. N. Bulmer. 2006. Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy. J. Leukoc. Biol. 80: 572-580.
4. Sykes, L., D. A. MacIntyre, X. J. Yap, T. G. Teoh, and P. R. Bennett. 2012. The Th1:Th2 dichotomy of pregnancy and preterm labour. Mediators Inflamm. 2012: 967629.
5. Moffett, A., and C. Loke. 2006. Immunology of placentation in eutherian mammals. Nat. Rev. Immunol. 6: 584-594.
6. Lash, G. E., K. Naruse, A. Robson, B. A. Innes, R. F. Searle, S. C. Robson, and J. N. Bulmer. 2011. Interaction between uterine natural killer cells and extravillous trophoblast cells: effect on cytokine and angiogenic growth factor production. Hum. Reprod. 26: 2289-2295.
7. Moffett, A., and F. Colucci. 2014. Uterine NK cells: Active regulators at the maternal-fetal interface. J. Clin. Invest. 124: 1872-1879.
8. Williams, P. J., R. F. Searle, S. C. Robson, B. A. Innes, and J. N. Bulmer. 2009. Decidual leucocyte populations in early to late gestation normal human pregnancy. J. Reprod. Immunol. 82: 24-31.
9. Blais, M.-E., T Dong, and S. Rowland-Jones. 2011. HLA-C as a mediator of natural killer and T-cell activation: spectator or key player? Immunology 133: 1-7.
10. Tilburgs, T., S. A. Scherjon, B. J. van der Mast, G. W. Haasnoot, M. Versteeg-V D Voort-Maarschalk, D. L. Roelen, J. J. van Rood, and F. H. Claas. 2009. Fetalmaternal HLA-C mismatch is associated with decidual T cell activation and induction of functional T regulatory cells. J. Reprod. Immunol. 82: 148-157.
11. Erlebacher, A., D. Vencato, K. A. Price, D. Zhang, and L. H. Glimcher. 2007. Constraints in antigen presentation severely restrict T cell recognition of the allogeneic fetus. J. Clin. Invest. 117: 1399-1411.
12. Collins, M. K., C.-S. Tay, and A. Erlebacher. 2009. Dendritic cell entrapment within the pregnant uterus inhibits immune surveillance of the maternal/fetal interface in mice. J. Clin. Invest. 119: 2062-2073.
13. Nancy, P., and A. Erlebacher. 2012. Epigenetic repression of chemokine expression at the maternal-fetal interface as a mechanism of feto-maternal tolerance. Med. Sci. 28: 1037-1039.
14. Lissauer, D., K. Piper, O. Goodyear, M. D. Kilby, and P. A. H. Moss. 2012. Fetalspecific CD8+ cytotoxic T cell responses develop during normal human pregnancy and exhibit broad functional capacity. J. Immunol. 189: 1072-1080.
15. Piper, K. P., A. McLarnon, J. Arrazi, C. Horlock, J. Ainsworth, M. D. Kilby, W. L. Martin, and P. A. Moss. 2007. Functional HY-specific CD8+ T cells are found in a high proportion of women following pregnancy with a male fetus. Biol. Reprod. 76: 96-101.
16. Verdijk, R. M., A. Kloosterman, J. Pool, M. van de Keur, A. M. Naipal, A. G. van Halteren, A. Brand, T. Mutis, and E. Goulmy. 2004. Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy. Blood 103: 1961-1964.
17. van Halteren, A. G., E. Jankowska-Gan, A. Joosten, E. Blokland, J. Pool, A. Brand, W. J. Burlingham, and E. Goulmy. 2009. Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members. Blood 114: 2263-2272.
18. Tilburgs, T., D. Schonkeren, M. Eikmans, N. M. Nagtzaam, G. Datema, G. M. Swings, F. Prins, J. M. van Lith, B. J. van der Mast, D. L. Roelen, et al. 2010. Human decidual tissue contains differentiated CD8+ effector-memory T cells with unique properties. J. Immunol. 185: 4470-4477.
19. Rowe, J. H., J. M. Ertelt, L. Xin, and S. S. Way. 2012. Pregnancy imprints regulatory memory that sustains anergy to fetal antigen. Nature 490: 102-106.
20. Samstein, R. M., A. Arvey, S. Z. Josefowicz, X. Peng, A. Reynolds, R. Sandstrom, S. Neph, P. Sabo, J. M. Kim, W. Liao, et al. 2012. Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell 151: 153-166.
21. Aluvihare, V. R., M. Kallikourdis, and A. G. Betz. 2004. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 5: 266-271.
22. Guleria, I., A. Khosroshahi, M. J. Ansari, A. Habicht, M. Azuma, H. Yagita, R. J. Noelle, A. Coyle, A. L. Mellor, S. J. Khoury, and M. H. Sayegh. 2005. A critical role for the programmed death ligand 1 in fetomaternal tolerance. J. Exp. Med. 202: 231-237.
23. Tanaka, K., M. J. Albin, X. Yuan, K. Yamaura, A. Habicht, T. Murayama, M. Grimm, A. M. Waaga, T. Ueno, R. F. Padera, et al. 2007. PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection. J. Immunol. 179: 5204-5210.
24. Chabtini, L., B. Mfarrej, M. Mounayar, B. Zhu, I. Batal, P. J. Dakle, B. D. Smith, O. Boenisch, N. Najafian, H. Akiba, et al. 2013. TIM-3 regulates innate immune cells to induce fetomaternal tolerance. J. Immunol. 190: 88-96.
25. Wang, S., X. Zhu, Y. Xu, D. Zhang, Y. Li, Y. Tao, H. Piao, D. Li, and M. Du. 2016. Programmed cell death-1 (PD-1) and T-cell immunoglobulin mucin-3 (Tim-3) regulate CD4+ T cells to induce type 2 helper T cell (Th2) bias at the maternal-fetal interface. Hum. Reprod. 31: 700-711.
26. Liang, S. C., Y. E. Latchman, J. E. Buhlmann, M. F. Tomczak, B. H. Horwitz, G. J. Freeman, and A. H. Sharpe. 2003. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur. J. Immunol. 33: 2706-2716.
27. Romero, P., A. Zippelius, I. Kurth, M. J. Pittet, C. Touvrey, E. M. Iancu, P. Corthesy, E. Devevre, D. E. Speiser, and N. Rufer. 2007. Four functionally distinct populations of human effector-memory CD8+ T lymphocytes. J. Immunol. 178: 4112-4119.
28. Tilburgs, T., D. L. Roelen, B. J. van der Mast, G. M. de Groot-Swings, C. Kleijburg, S. A. Scherjon, and F. H. Claas. 2008. Evidence for a selective migration of fetus-specific CD4+CD25bright regulatory T cells from the peripheral blood to the decidua in human pregnancy. J. Immunol. 180: 5737-5745.
29. Lim, E. S., L. I. Wu, H. S. Malik, and M. Emerman. 2012. The function and evolution of the restriction factor Viperin in primates was not driven by lentiviruses. Retrovirology 9: 55.
30. Hata, M., S. Takahara, H. Tsuzaki, Y. Ishii, K. Nakata, K. S. Akagawa, and K. Satoh. 2009. Expression of Th2-skewed pathology mediators in monocytederived type 2 of dendritic cells (DC2). Immunol. Lett. 126: 29-36.
31. Wang, X., J. H. Dong, W. Z. Zhang, J. J. Leng, S. W. Cai, M. Y. Chen, and X. Yang. 2014. Double stranded RNA-dependent protein kinase promotes the tumorigenic phenotype in HepG2 hepatocellular carcinoma cells by activating STAT3. Oncol. Lett. 8: 2762-2768.
32. Oshiumi, H., E. J. Mifsud, and T. Daito. 2016. Links between recognition and degradation of cytoplasmic viral RNA in innate immune response. Rev. Med. Virol. 26: 90-101.
33. Pinilla-Vera, M., Z. Xiong, Y. Zhao, J. Zhao, M. P. Donahoe, S. Barge, W. T. Horne, J. K. Kolls, B. J. McVerry, A. Birukova, et al. 2016. Full spectrum of LPS activation in alveolar macrophages of healthy volunteers by whole transcriptomic profiling. PLoS One 11: e0159329.
34. Dong, F., Y. Zhang, F. Xia, Y. Yang, S. Xiong, L. Jin, and J. Zhang. 2014. Genome-wide miRNA profiling of villus and decidua of recurrent spontaneous abortion patients. Reproduction 148: 33-41.
35. Koopman, L. A., H. D. Kopcow, B. Rybalov, J. E. Boyson, J. S. Orange, F. Schatz, R. Masch, C. J. Lockwood, A. D. Schachter, P. J. Park, and J. L. Strominger. 2003. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J. Exp. Med. 198: 1201-1212.
36. Meggyes, M., E. Miko, B. Polgar, B. Bogar, B. Farkas, Z. Illes, and L. Szereday. 2014. Peripheral blood TIM-3 positive NK and CD8+ T cells throughout pregnancy: TIM-3/galectin-9 interaction and its possible role during pregnancy. PLoS One 9: e92371.
37. Deák, M., A. Hornung, J. Novák, D. Demydenko, E. Szabó, A. Czibula, R. Fajka-Boja, E. Kriston-Pál, E. Monostori, and L. Kovács. 2015. Novel role for galectin-1 in T-cells under physiological and pathological conditions. Immunobiology 220: 483-489.
38. Schumacher, A., N. Brachwitz, S. Sohr, K. Engeland, S. Langwisch, M. Dolaptchieva, T. Alexander, A. Taran, S. F. Malfertheiner, S. D. Costa, et al. 2009. Human chorionic gonadotropin attracts regulatory T cells into the fetalmaternal interface during early human pregnancy. J. Immunol. 182: 5488-5497.
39. Lissauer, D., S. A. Eldershaw, C. F. Inman, A. Coomarasamy, P. A. Moss, and M. D. Kilby. 2015. Progesterone promotes maternal-fetal tolerance by reducing human maternal T-cell polyfunctionality and inducing a specific cytokine profile. Eur. J. Immunol. 45: 2858-2872.
40. Raghupathy, R., E. Al Mutawa, M. Makhseed, F. Azizieh, and J. Szekeres-Bartho. 2005. Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent miscarriage. BJOG 112: 1096-1101.
41. Tilburgs, T., D. L. Roelen, B. J. van der Mast, J. J. van Schip, C. Kleijburg, G. M. de Groot-Swings, H. H. Kanhai, F. H. Claas, and S. A. Scherjon. 2006. Differential distribution of CD4+CD25bright and CD8+CD282 T-cells in decidua and maternal blood during human pregnancy. Placenta. 27(Suppl. A): S47-S53.
42. Topalian, S. L., F. S. Hodi, J. R. Brahmer, S. N. Gettinger, D. C. Smith, D. F. McDermott, J. D. Powderly, R. D. Carvajal, J. A. Sosman, M. B. Atkins, et al. 2012. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N. Engl. J. Med. 366: 2443-2454.
43. Wang, S. C., Y. H. Li, H. L. Piao, X. W. Hong, D. Zhang, Y. Y. Xu, Y. Tao, Y. Wang, M. M. Yuan, D. J. Li, and M. R. Du. 2015. PD-1 and Tim-3 pathways are associated with regulatory CD8+ T-cell function in decidua and maintenance of normal pregnancy. Cell Death Dis. 6: e1738.
44. Veras, E., R. J. Kurman, T. L. Wang, and I. M. Shih. 2016. PD-L1 expression in human placentas and gestational trophoblastic diseases. Int. J. Gynecol. Pathol. 36: 146-153.
45. Taglauer, E. S., T. M. Yankee, and M. G. Petroff. 2009. Maternal PD-1 regulates accumulation of fetal antigen-specific CD8+ T cells in pregnancy. J. Reprod. Immunol. 80: 12-21.
46. Chard, T., P. H. Craig, M. Menabawey, and C. Lee. 1986. Alpha interferon in human pregnancy. Br. J. Obstet. Gynaecol. 93: 1145-1149.
47. Khan, N. U., A. Gibson, and A. K. Foulis. 1990. The distribution of immunoreactive interferon-Alpha in formalin-fixed paraffin-embedded normal human foetal and infant tissues. Immunology 71: 230-235.
48. Bannert, N., and R. Kurth. 2004. Retroelements and the human genome: new perspectives on an old relation. Proc. Natl. Acad. Sci. USA 101(Suppl. 2): 14572-14579.
49. Tristem, M. 2000. Identification and characterization of novel human endogenous retrovirus families by phylogenetic screening of the human genome mapping project database. J. Virol. 74: 3715-3730.
50. Turner, G., M. Barbulescu, M. Su, M. I. Jensen-Seaman, K. K. Kidd, and J. Lenz. 2001. Insertional polymorphisms of full-length endogenous retroviruses in humans. Curr. Biol. 11: 1531-1535.
51. Blond, J. L., F. Besème, L. Duret, O. Bouton, F. Bedin, H. Perron, B. Mandrand, and F. Mallet. 1999. Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family. J. Virol. 73: 1175-1185.
52. Mi, S., X. Lee, X. Li, G. M. Veldman, H. Finnerty, L. Racie, E. LaVallie, X. Y. Tang, P. Edouard, S. Howes, et al. 2000. Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 403: 785-789.
53. Holder, B. S., C. L. Tower, K. Forbes, M. J. Mulla, J. D. Aplin, and V. M. Abrahams. 2012. Immune cell activation by trophoblast-derived microvesicles is mediated by syncytin 1. Immunology 136: 184-191.
54. Kämmerer, U., A. Germeyer, S. Stengel, M. Kapp, and J. Denner. 2011. Human endogenous retrovirus K (HERV-K) is expressed in villous and extravillous cytotrophoblast cells of the human placenta. J. Reprod. Immunol. 91: 1-8.
55. Denny, M. F., S. Thacker, H. Mehta, E. C. Somers, T. Dodick, F. J. Barrat, W. J. McCune, and M. J. Kaplan. 2007. Interferon-A promotes abnormal vasculogenesis in lupus: A potential pathway for premature atherosclerosis. Blood 110: 2907-2915.
56. Andrade, D., M. Kim, L. P. Blanco, S. A. Karumanchi, G. C. Koo, P. Redecha, K. Kirou, A. M. Alvarez, M. J. Mulla, M. K. Crow, et al. 2015. Interferon-A and angiogenic dysregulation in pregnant lupus patients who develop preeclampsia. Arthritis Rheumatol. 67: 977-987.
57. Lu, J., Q. Dong, B. Zhang, X. Wang, B. Ye, F. Zhang, X. Song, G. Gao, J. Mu, Z. Wang, et al. 2015. Chloride intracellular channel 1 (CLIC1) is activated and functions as an oncogene in pancreatic cancer. Med. Oncol. 32: 616.
58. Zhao, W., M. Lu, and Q. Zhang. 2015. Chloride intracellular channel 1 regulates migration and invasion in gastric cancer by triggering the ROS-mediated p38 MAPK signaling pathway. Mol. Med. Rep. 12: 8041-8047.
59. Tian, Y., Y. Guan, Y. Jia, Q. Meng, and J. Yang. 2014. Chloride intracellular channel 1 regulates prostate cancer cell proliferation and migration through the MAPK/ERK pathway. Cancer Biother. Radiopharm. 29: 339-344.
60. Averaimo, S., R. H. Milton, M. R. Duchen, and M. Mazzanti. 2010. Chloride intracellular channel 1 (CLIC1): sensor and effector during oxidative stress. FEBS Lett. 584: 2076-2084.
61. Patel, J., K. Landers, R. H. Mortimer, and K. Richard. 2010. Regulation of hypoxia inducible factors (HIF) in hypoxia and normoxia during placental development. Placenta 31: 951-957.
62. Murthi, P., J. L. Stevenson, T. T. Money, A. J. Borg, S. P. Brennecke, and N. M. Gude, . 2012. Placental CLIC3 is increased in fetal growth restriction and pre-eclampsia affected human pregnancies. Placenta 33: 741-744.
63. Ilarregui, J. M., D. O. Croci, G. A. Bianco, M. A. Toscano, M. Salatino, M. E. Vermeulen, J. R. Geffner, and G. A. Rabinovich. 2009. Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. Nat. Immunol. 10: 981-991.
64. Blaser, C., M. Kaufmann, C. Müller, C. Zimmermann, V. Wells, L. Mallucci, and H. Pircher. 1998. b-Galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells. Eur. J. Immunol. 28: 2311-2319.
65. Fuertes, M. B., L. L. Molinero, M. A. Toscano, J. M. Ilarregui, N. Rubinstein, L. Fainboim, N. W. Zwirner, and G. A. Rabinovich. 2004. Regulated expression of galectin-1 during T-cell activation involves Lck and Fyn kinases and signaling through MEK1/ERK, p38 MAP kinase and p70S6 kinase. Mol. Cell. Biochem. 267: 177-185.
66. Rabinovich, G. A., and M. A. Toscano. 2009. Turning "sweet" on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat. Rev. Immunol. 9: 338-352.
67. Zhu, C., A. C. Anderson, A. Schubart, H. Xiong, J. Imitola, S. J. Khoury, X. X. Zheng, T. B. Strom, and V. K. Kuchroo. 2005. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat. Immunol. 6: 1245-1252.
68. Wu, C., T. Thalhamer, R. F. Franca, S. Xiao, C. Wang, C. Hotta, C. Zhu, M. Hirashima, A. C. Anderson, and V. K. Kuchroo. 2014. Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells. Immunity 41: 270-282.
69. Fraser, R., G. S. J. Whitley, B. Thilaganathan, and J. E. Cartwright. 2015. Decidual natural killer cells regulate vessel stability: implications for impaired spiral artery remodelling. J. Reprod. Immunol. 110: 54-60.
70. Saito, S., M. Sakai, Y. Sasaki, K. Tanebe, H. Tsuda, and T. Michimata. 1999. Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia. Clin. Exp. Immunol. 117: 550-555.
71. Saito, S., A. Nakashima, T. Shima, and M. Ito. 2010. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am. J. Reprod. Immunol. 63: 601-610.
72. Leavey, K., S. J. Benton, D. Grynspan, J. C. Kingdom, S. A. Bainbridge, and B. J. Cox. 2016. Unsupervised placental gene expression profiling identifies clinically relevant subclasses of human preeclampsia. Hypertension 68: 137-147.
73. Tamblyn, J. A., D. M. Lissauer, R. Powell, P. Cox, and M. D. Kilby. 2013. The immunological basis of villitis of unknown etiology-review. Placenta 34: 846-855.
74. Redline, R. W., and P. Patterson. 1993. Villitis of unknown etiology is associated with major infiltration of fetal tissue by maternal inflammatory cells. Am. J. Pathol. 143: 473-479.
75. Kapur, P., D. Rakheja, A. M. Gomez, J. Sheffield, P. Sanchez, and B. B. Rogers. 2004. Characterization of inflammation in syphilitic villitis and in villitis of unknown etiology. Pediatr. Dev. Pathol. 7: 453-458.
76. Redline, R. W. 2007. Villitis of unknown etiology: noninfectious chronic villitis in the placenta. Hum. Pathol. 38: 1439-1446.